BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16047493)

  • 1. Colon targeted delivery systems: review of polysaccharides for encapsulation and delivery.
    Kosaraju SL
    Crit Rev Food Sci Nutr; 2005; 45(4):251-8. PubMed ID: 16047493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon.
    Jain A; Gupta Y; Jain SK
    J Pharm Pharm Sci; 2007; 10(1):86-128. PubMed ID: 17498397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharides for colon targeted drug delivery.
    Chourasia MK; Jain SK
    Drug Deliv; 2004; 11(2):129-48. PubMed ID: 15200012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the period of adaptation on the digestibility of diets containing different types of indigestible polysaccharides in rats.
    Brunsgaard G; Bach Knudsen KE; Eggum BO
    Br J Nutr; 1995 Dec; 74(6):833-48. PubMed ID: 8562570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in colon drug delivery systems.
    Arévalo-Pérez R; Maderuelo C; Lanao JM
    J Control Release; 2020 Nov; 327():703-724. PubMed ID: 32941930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharides: a targeting strategy for colonic drug delivery.
    Shah N; Shah T; Amin A
    Expert Opin Drug Deliv; 2011 Jun; 8(6):779-96. PubMed ID: 21506904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raft-forming agents: antireflux formulations.
    Kapadia CJ; Mane VB
    Drug Dev Ind Pharm; 2007 Dec; 33(12):1350-61. PubMed ID: 18097809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel dissolution media for testing drug release from a nanostructured polysaccharide-based colon specific drug delivery system: an approach to alternative colon media.
    Kotla NG; Singh S; Maddiboyina B; Sunnapu O; Webster TJ
    Int J Nanomedicine; 2016; 11():1089-95. PubMed ID: 27051284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro and In-vivo Pharmacokinetic Evaluation of Guar Gum-Eudragit® S100 Based Colon-targeted Spheroids of Sulfasalazine Co-administered with Probiotics.
    Sharma A; Kumar B; Singh SK; Gulati M; Vaidya Y; ; Rathee H; Ghai D; Malik AH; Yadav AK; Maharshi P; Bawa P; Rajesh SY; Sharma P; Pandey NK; Mohanta S
    Curr Drug Deliv; 2018; 15(3):367-387. PubMed ID: 29219056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of co-administration of probiotics with polysaccharide based colon targeted delivery systems to optimize site specific drug release.
    Prudhviraj G; Vaidya Y; Singh SK; Yadav AK; Kaur P; Gulati M; Gowthamarajan K
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):164-72. PubMed ID: 26415986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
    Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biodegradable polymers for colon-specific drug delivery].
    Musiał W; Kubis A
    Polim Med; 2005; 35(4):51-61. PubMed ID: 16619797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery.
    Adkin DA; Kenyon CJ; Lerner EI; Landau I; Strauss E; Caron D; Penhasi A; Rubinstein A; Wilding IR
    Pharm Res; 1997 Jan; 14(1):103-7. PubMed ID: 9034229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current applications of polysaccharides in colon targeting.
    Hovgaard L; Brøndsted H
    Crit Rev Ther Drug Carrier Syst; 1996; 13(3-4):185-223. PubMed ID: 9016381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysaccharides in colon-specific drug delivery.
    Sinha VR; Kumria R
    Int J Pharm; 2001 Aug; 224(1-2):19-38. PubMed ID: 11472812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic opportunities in colon-specific drug-delivery systems.
    Patel M; Shah T; Amin A
    Crit Rev Ther Drug Carrier Syst; 2007; 24(2):147-202. PubMed ID: 17725524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactomannan-PEI based non-viral vectors for targeted delivery of plasmid to macrophages and hepatocytes.
    Bansal R; Singh AK; Gandhi RP; Pant AB; Kumar P; Gupta KC
    Eur J Pharm Biopharm; 2014 Aug; 87(3):461-71. PubMed ID: 24825126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-triggered colonic delivery: robustness of the polysaccharide approach in the fed state in man.
    Basit AW; Short MD; McConnell EL
    J Drug Target; 2009 Jan; 17(1):64-71. PubMed ID: 19016069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of guargum-based colon-targeted oral drug delivery systems of celecoxib in human volunteers.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):273-80. PubMed ID: 12587957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.